Product Images Venlafaxine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 71335-1338 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Venlafaxine hydrochloride extended-release capsules, USP - e5d724aa bc22 4503 b0e0 87b3b1d4a77e 01

Venlafaxine hydrochloride extended-release capsules, USP - e5d724aa bc22 4503 b0e0 87b3b1d4a77e 01

This is a table indicating drug interactions and recommendations for use with venlafaxine in CYP2D6 EM's and PM's. Some drugs like diazepam and cimetidine need caution during concomitant use while others like ketoconazole and indinavir require monitoring of blood pressure. The recommended adjustments range from avoiding concomitant use to no dose adjustment. The clinical significance of some interactions is unknown. The table also shows PK fold change and 90% C for Cmax and AUC.*

Venlafaxine hydrochloride extended-release capsules, USP - e5d724aa bc22 4503 b0e0 87b3b1d4a77e 02

Venlafaxine hydrochloride extended-release capsules, USP - e5d724aa bc22 4503 b0e0 87b3b1d4a77e 02

This is a list of drugs that may interact with each other. The list includes drugs such as Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, and Lithium. There are also recommendations for certain analytes such as PKFold Change and 90% C Recommendation for each drug. The text includes information on different drug interactions, such as whether concomitant use should be avoided or if there is no need for a dose adjustment. There is also a section detailing changes relative to the reference value.*

Venlafaxine hydrochloride extended-release capsules, USP - e5d724aa bc22 4503 b0e0 87b3b1d4a77e 03

Venlafaxine hydrochloride extended-release capsules, USP - e5d724aa bc22 4503 b0e0 87b3b1d4a77e 03

This document appears to be a report on the effects of various factors on the PK of analytes, particularly Venlafaxine. The factors include age, gender, hepatic and renal impairment, and a genetic polymorphism (CYP2D8). The report recommends adjusting the dose of Venlafaxine for certain populations based on fold change and 90% CI. However, the document contains many errors and typos in the text making it difficult to interpret.*

Venlafaxine hydrochloride extended-release capsules, USP - e5d724aa bc22 4503 b0e0 87b3b1d4a77e 04

Venlafaxine hydrochloride extended-release capsules, USP - e5d724aa bc22 4503 b0e0 87b3b1d4a77e 04

The text "eHCI" and "H4C0 C" are not readable. The readable part of the text is "venlafaxine hydrochloride", which is a medication used to treat depression, anxiety, and panic attacks. It belongs to the class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and reduce feelings of anxiety and depression.*

Label - lbl713351338

Label - lbl713351338

This appears to be a label of Venlafaxine HCL, a prescription drug used to treat major depressive disorder, anxiety disorders, and panic disorder. The label shows the brand name, the dosage and type of the capsule, possible side effects, storage instructions, manufacturer's details, and the expiration date. The National Drug Code (NDC) is also displayed which is used to identify drugs in the market.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.